Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „relevant“
Suchtreffer
Begriffe & Kennungen
Ablymico · 4.5 · No interaction study has been performed. A clinically relevant interaction with active substances with poor so
Eintrag öffnenAbraxane · 4.8 · This section contains the most common and clinically relevant adverse reactions related to Abraxane.
Eintrag öffnenActos · 4.5 · Interaction studies have shown that pioglitazone has no relevant effect on either the pharmacokinetics or phar
Eintrag öffnenAdempas · 4.5 · Riociguat and its main metabolite are strong inhibitors of CYP1A1 in vitro. Therefore, clinically relevant dru
Eintrag öffnenAdempas · 4.5 · Riociguat and its main metabolite are strong inhibitors of CYP1A1 in vitro. Therefore, clinically relevant dru
Eintrag öffnenAerinaze · 4.5 · Desloratadine No clinically relevant interactions or changes in desloratadine plasma concentrations were obser
Eintrag öffnenAerius · 4.5 · No clinically relevant interactions were observed in clinical trials with desloratadine tablets in which eryth
Eintrag öffnenAerius · 4.5 · No clinically relevant interactions were observed in clinical trials with desloratadine tablets in which eryth
Eintrag öffnenAkynzeo · 4.5 · No clinically relevant pharmacokinetic interactions have been observed between oral netupitant and oral palono
Eintrag öffnenAkynzeo · 4.5 · No clinically relevant pharmacokinetic interactions have been observed between oral netupitant and oral palono
Eintrag öffnenAkynzeo · 4.5 · No clinically relevant pharmacokinetic interactions have been observed between oral netupitant and oral palono
Eintrag öffnenAkynzeo · 4.5 · No clinically relevant pharmacokinetic interactions have been observed between oral netupitant and oral palono
Eintrag öffnenAmbrisentan Viatris (previously Ambrisentan Mylan) · 4.5 · Ambrisentan does not inhibit or induce phase I or II drug metabolising enzymes at clinically relevant concentr
Eintrag öffnenAmbrisentan Viatris (previously Ambrisentan Mylan) · 4.5 · In vitro, ambrisentan has no inhibitory effect on human transporters at clinically relevant concentrations, in
Eintrag öffnenAmbrisentan Viatris (previously Ambrisentan Mylan) · 4.5 · Steady-state administration of ambrisentan in healthy volunteers had no clinically relevant effects on the sin
Eintrag öffnenAvastin · 4.5 · Effect of antineoplastic agents on bevacizumab pharmacokinetics No clinically relevant interaction of co-admin
Eintrag öffnenAvastin · 4.5 · Effect of bevacizumab on the pharmacokinetics of other antineoplastic agents No clinically relevant interactio
Eintrag öffnenAxura · 4.5 · 5 In single-dose pharmacokinetic (PK) studies in young healthy subjects no relevant active substance- active s
Eintrag öffnenAxura · 4.5 · In a clinical study in young healthy subjects no relevant effect of memantine on the pharmacokinetics of galan
Eintrag öffnenAxura · 4.5 · In a clinical study in young healthy subjects no relevant effect of memantine on the pharmacokinetics of galan
Eintrag öffnen